top of page


Promising Breakthrough in Ovarian Cancer Treatment: Merck's Positive Phase 3 Trial Results
Merck has announced a significant step forward in ovarian cancer research with the successful results of its Phase 3 KEYLYNK-001 trial ,...

The Female Body
Dec 12, 20243 min read
Â
Â
Â
bottom of page